Home

Par

Tagged:  
Par Pharma gets FDA nod for generic version of Ultram
Reuters
Tagged:  
Par Pharmaceutical profit jumps, revenue nearly doubles
Yahoo/AP
Tagged:  
Mylan, Inc. Lags Behind Drugs - Generic Industry; MYL, PRX, WPI
Learning Markets
Tagged:  
BioAlliance shares rise as FDA clears drug application
Forbes/Reuters
Tagged:  
Par Pharmaceutical cites favorable ruling in patent dispute over pain drug Ultram ER
Chicago Tribune, IL
Tagged:  
Par Gets Tentative Approval For Once-Daily Tramadol Generic
WSJ Online
Tagged:  
MDRNA, Inc. Receives Full FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis; Par Pharmaceutical Companies, Inc. Launches Product
Yahoo
Tagged:  
Par Pharma launched generic Risperdal M-Tab
Yahoo/AP
Tagged:  
Par Pharma Q1 profit jumps, shares rise
Reuters
Tagged:  
Par Pharmaceutical Enters Into Agreement With Reliant Pharmaceuticals to Settle Patent Litigation Over Rythmol(R) SR
PR Newswire
12next ›last »
Syndicate content